AMETEK, Inc. $AME Shares Acquired by Riversedge Advisors LLC

Riversedge Advisors LLC lifted its position in shares of AMETEK, Inc. (NYSE:AME) by 154.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 5,315 shares of the technology company’s stock after buying an additional 3,223 shares during the period. Riversedge Advisors LLC’s holdings in AMETEK were worth $1,317,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wedmont Private Capital lifted its stake in shares of AMETEK by 159.5% during the third quarter. Wedmont Private Capital now owns 9,559 shares of the technology company’s stock worth $2,368,000 after purchasing an additional 5,875 shares in the last quarter. LifeGoal Investments LLC acquired a new stake in shares of AMETEK in the third quarter valued at about $259,000. Mn Services Vermogensbeheer B.V. grew its stake in shares of AMETEK by 93.5% in the third quarter. Mn Services Vermogensbeheer B.V. now owns 128,287 shares of the technology company’s stock valued at $31,781,000 after buying an additional 61,984 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of AMETEK by 173.1% during the 3rd quarter. GAMMA Investing LLC now owns 22,908 shares of the technology company’s stock valued at $5,675,000 after buying an additional 14,520 shares during the period. Finally, Conrad Siegel Investment Advisors Inc. raised its holdings in shares of AMETEK by 30.5% during the 3rd quarter. Conrad Siegel Investment Advisors Inc. now owns 2,266 shares of the technology company’s stock valued at $561,000 after buying an additional 529 shares during the period. 87.43% of the stock is owned by hedge funds and other institutional investors.

AMETEK Stock Up 0.6%

Shares of AME traded up $1.38 during trading on Friday, reaching $248.90. The company’s stock had a trading volume of 250,031 shares, compared to its average volume of 1,302,952. The company has a market cap of $57.05 billion, a price-to-earnings ratio of 36.39, a P/E/G ratio of 2.35 and a beta of 0.96. The company has a quick ratio of 0.76, a current ratio of 1.21 and a debt-to-equity ratio of 0.09. The company has a fifty day moving average of $244.70 and a two-hundred day moving average of $235.40. AMETEK, Inc. has a twelve month low of $179.24 and a twelve month high of $261.16.

AMETEK (NYSE:AME) last issued its quarterly earnings results on Tuesday, August 4th. The technology company reported $2.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.10. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $1.95 billion. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. The business’s revenue was up 15.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.78 earnings per share. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. On average, sell-side analysts predict that AMETEK, Inc. will post 8.42 EPS for the current fiscal year.

AMETEK Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, September 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.5%. AMETEK’s dividend payout ratio (DPR) is presently 19.88%.

Analyst Upgrades and Downgrades

Several analysts have issued reports on AME shares. KeyCorp increased their price objective on shares of AMETEK from $260.00 to $295.00 and gave the company an “overweight” rating in a research report on Wednesday, August 5th. Citigroup upped their target price on shares of AMETEK from $257.00 to $261.00 and gave the company a “neutral” rating in a research note on Wednesday, August 5th. Morgan Stanley set a $275.00 price target on shares of AMETEK in a report on Friday. Zacks Research raised shares of AMETEK from a “hold” rating to a “strong-buy” rating in a research note on Tuesday. Finally, DA Davidson set a $285.00 price objective on shares of AMETEK in a report on Wednesday. Two research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, AMETEK currently has an average rating of “Moderate Buy” and a consensus price target of $268.88.

Insider Buying and Selling

In related news, insider David Hermance sold 6,608 shares of AMETEK stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $254.00, for a total value of $1,678,432.00. Following the completion of the transaction, the insider directly owned 42,509 shares in the company, valued at approximately $10,797,286. This trade represents a 13.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.54% of the company’s stock.

Key Stories Impacting AMETEK

Here are the key news stories impacting AMETEK this week:

• Positive Sentiment: Morgan Stanley raised its price target to $275 from $245, implying additional upside from recent trading levels and reinforcing the bullish view on AMETEK’s earnings outlook. Morgan Stanley Adjusts Price Target on AMETEK to $275 From $245
• Positive Sentiment: Zacks Research upgraded AMETEK from “Hold” to “Strong-Buy,” improving the stock’s near-term analyst sentiment. AMETEK Upgraded to Strong-Buy at Zacks Research
• Positive Sentiment: Zacks raised EPS estimates across 2026-2028, including FY2026 to $8.40 from $8.27, FY2027 to $9.58 from $8.74, and FY2028 to $10.66 from $9.33. The revisions suggest stronger expected earnings growth and support the higher valuation, while Zacks maintained its “Strong-Buy” rating.
• Positive Sentiment: AMETEK may beat estimates again in its upcoming report. Zacks cited the company’s history of earnings surprises and a favorable combination of indicators supporting the possibility of another beat. The company’s latest reported quarter also exceeded expectations, with revenue up 15% year over year. Why AMETEK Could Beat Earnings Estimates Again
• Neutral Sentiment: At approximately 36 times earnings, AMETEK is priced for continued execution. Its shares are near the 52-week high, so further gains may depend on the company converting the stronger forecasts into actual results; the modest premarket weakness was not supported by a major negative fundamental announcement.

AMETEK Profile

AMETEK, Inc (NYSE: AME) is a global manufacturer of industrial technology products. The company develops and produces electronic instruments and electromechanical devices used in process, industrial, aerospace, power, energy, and other specialized markets.

AMETEK’s Electronic Instruments segment supplies products such as process and analytical instruments, measurement and testing equipment, power-quality monitoring systems, automation and control solutions, and equipment for aerospace and defense applications.